Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigenPlasmodium falciparumFVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01

✍ Scribed by Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, Margaret Koech…

• Book ID: 120686351
• Publisher: BioMed Central
• Year: 2013
• Tongue: English
• Weight: 328 KB
• Volume: 12
• Category: Article
• ISSN: 1475-2875
• DOI: 10.1186/1475-2875-12-29